Comment
doi: 10.1038/nrclinonc.2013.238.
Epub 2013 Dec 17.
Targeted therapies: Juggling combinations--not the way forward
- PMID: 24343669
- DOI: 10.1038/nrclinonc.2013.238
Item in Clipboard
Comment
Targeted therapies: Juggling combinations--not the way forward
Nat Rev Clin Oncol.
2014 Feb.
No abstract available
Comment on
-
Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.J Clin Oncol. 2014 Mar 10;32(8):752-9. doi: 10.1200/JCO.2013.50.5305. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297945 Clinical Trial.
-
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.J Clin Oncol. 2014 Mar 10;32(8):760-7. doi: 10.1200/JCO.2013.50.3961. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297950 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
